According to clinical statistics, the rate of COVID-19-related mortality was higher in patients with hypertension, diabetes, and chronic cardiovascular disease, and ACE2 expression was significantly increased in patients with diabetes and hypertension after ACEI/ARB treatment. Here, ACE2 is linked to Hypertension.